JPH11130798A5 - - Google Patents

Info

Publication number
JPH11130798A5
JPH11130798A5 JP1998230368A JP23036898A JPH11130798A5 JP H11130798 A5 JPH11130798 A5 JP H11130798A5 JP 1998230368 A JP1998230368 A JP 1998230368A JP 23036898 A JP23036898 A JP 23036898A JP H11130798 A5 JPH11130798 A5 JP H11130798A5
Authority
JP
Japan
Prior art keywords
amino acid
insulin
cysteine
arg
arginine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998230368A
Other languages
English (en)
Japanese (ja)
Other versions
JP4291900B2 (ja
JPH11130798A (ja
Filing date
Publication date
Priority claimed from DE19735711A external-priority patent/DE19735711C2/de
Application filed filed Critical
Publication of JPH11130798A publication Critical patent/JPH11130798A/ja
Publication of JPH11130798A5 publication Critical patent/JPH11130798A5/ja
Application granted granted Critical
Publication of JP4291900B2 publication Critical patent/JP4291900B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP23036898A 1997-08-18 1998-08-17 正しく結合したシスチン橋を有するインスリン前駆体を取得するための改良された方法 Expired - Lifetime JP4291900B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19735711A DE19735711C2 (de) 1997-08-18 1997-08-18 Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
DE19735711:3 1997-08-18

Publications (3)

Publication Number Publication Date
JPH11130798A JPH11130798A (ja) 1999-05-18
JPH11130798A5 true JPH11130798A5 (https=) 2005-11-04
JP4291900B2 JP4291900B2 (ja) 2009-07-08

Family

ID=7839275

Family Applications (1)

Application Number Title Priority Date Filing Date
JP23036898A Expired - Lifetime JP4291900B2 (ja) 1997-08-18 1998-08-17 正しく結合したシスチン橋を有するインスリン前駆体を取得するための改良された方法

Country Status (20)

Country Link
US (3) US5986048A (https=)
EP (2) EP0906918B1 (https=)
JP (1) JP4291900B2 (https=)
KR (2) KR100537842B1 (https=)
CN (3) CN1132845C (https=)
AR (1) AR016821A1 (https=)
AT (2) ATE217636T1 (https=)
AU (1) AU744824B2 (https=)
BR (2) BRPI9816233B8 (https=)
CA (1) CA2245151C (https=)
CZ (1) CZ295679B6 (https=)
DE (3) DE19735711C2 (https=)
DK (2) DK0980874T3 (https=)
ES (2) ES2177178T3 (https=)
HU (2) HU228161B1 (https=)
ID (1) ID20717A (https=)
PL (1) PL191901B1 (https=)
PT (2) PT906918E (https=)
RU (2) RU2205836C2 (https=)
TR (1) TR199801587A3 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
DE19930676B4 (de) 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
WO2001046453A1 (en) * 1999-12-22 2001-06-28 Novo Nordisk A/S Method for extractive refolding of scrambled single-chain polypeptides
US20030212248A1 (en) * 2000-07-12 2003-11-13 Furman Thomas Charles Process to increase protein stability
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
DE102004015965A1 (de) * 2004-04-01 2005-10-20 Aventis Pharma Gmbh Verfahren zur Gewinnung von Insulinen durch verbesserte Luftbegasung der Faltung
NZ568809A (en) 2005-12-22 2011-08-26 Genentech Inc Recovering and purification of VEGF proteins from prokaryotic cells using polyanionic agents
US20080125580A1 (en) 2006-07-14 2008-05-29 Genentech, Inc. Refolding of Recombinant Proteins
JP5244175B2 (ja) * 2007-07-03 2013-07-24 アムジエン・インコーポレーテツド 封入体乾燥重量を用いたタンパク質の測定
RU2451750C2 (ru) * 2007-09-24 2012-05-27 Общество С Ограниченной Ответственностью "Герофарм" Способ получения рекомбинантного с-пептида проинсулина человека
CN102007143B (zh) 2008-01-09 2015-08-26 塞诺菲-安万特德国有限公司 具有超延迟时效特征的新型胰岛素衍生物
WO2009133529A2 (en) * 2008-04-30 2009-11-05 Wockhardt Research Centre Processes for refolding of insulin
CN102256618A (zh) 2008-10-17 2011-11-23 赛诺菲-安万特德国有限公司 胰岛素和glp-1激动剂的组合
TR201809460T4 (tr) 2009-11-13 2018-07-23 Sanofi Aventis Deutschland Bir GLP- 1-agonisti, bir insülin ve metiyonin içeren farmasötik bileşim.
NZ599847A (en) 2009-11-13 2013-09-27 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
WO2012028172A1 (en) 2010-08-30 2012-03-08 Sanofi-Aventis Deutschland Gmbh Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
US12157766B2 (en) * 2012-08-05 2024-12-03 Absci Corporation Cytoplasmic expression system
EP2931301B2 (en) 2012-12-17 2021-09-15 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
TWI708782B (zh) * 2013-02-26 2020-11-01 南韓商韓美藥品股份有限公司 新穎胰島素類似物及其用途
CN103694339B (zh) * 2013-12-04 2017-10-13 珠海联邦制药股份有限公司 一种甘精胰岛素前体的复性方法
EP3116531B1 (en) 2014-03-14 2021-10-20 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
PE20171622A1 (es) 2014-12-12 2017-11-02 Sanofi Aventis Deutschland Formulacion de relacion fija de insulina glargina/lixisenatida
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
CN104911203A (zh) * 2015-06-30 2015-09-16 成都易胜科生物科技有限公司 一种重组人胰岛素的工业制备方法
US10745457B2 (en) 2015-09-02 2020-08-18 Merck Sharp & Dohme Corp. Process for obtaining insulin with correctly formed disulfide bonds
US10689430B2 (en) 2016-05-25 2020-06-23 Merck Sharp & Dohme Corp. Insulin receptor partial agonists
WO2018018613A1 (zh) 2016-07-29 2018-02-01 广东东阳光药业有限公司 一种提高抗体纯度的细胞培养基和培养方法
CN113773391B (zh) * 2020-06-09 2023-10-20 宁波鲲鹏生物科技有限公司 一种门冬胰岛素的制备方法
CN113773400B (zh) * 2020-06-09 2023-08-18 宁波鲲鹏生物科技有限公司 一种门冬胰岛素衍生物及其应用
CN113773396A (zh) * 2020-06-10 2021-12-10 宁波鲲鹏生物科技有限公司 一种地特胰岛素衍生物及其应用
JP7749397B2 (ja) * 2021-09-30 2025-10-06 キヤノン株式会社 超音波ファントム及び超音波ファントムの製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199391A (en) * 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
DE3501641A1 (de) * 1985-01-19 1986-07-24 Hoechst Ag, 6230 Frankfurt Verfahren zur gewinnung von insulin-vorlaeufern aus reaktionsgemischen, die bei der faltung von insulin-vorlaeufern aus den entsprechenden s-sulfonaten anfallen
IL95495A (en) * 1989-08-29 1996-10-16 Hoechst Ag Fusion proteins their preparation and use
RU2045535C1 (ru) * 1991-06-18 1995-10-10 Институт биоорганической химии им.М.М.Шемякина и Ю.А.Овчинникова РАН Способ получения проинсулина человека
DK0600372T3 (da) * 1992-12-02 1997-08-11 Hoechst Ag Fremgangsmåde til fremstilling af proinsulin med korrekt forbundne cystinbroer.
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
RU2081122C1 (ru) * 1994-06-16 1997-06-10 Институт биоорганической химии им.М.М.Шемякина и Ю.А.Овчинникова РАН Способ выделения и очистки инсулина или его биотехнологических предшественников
NZ279002A (en) * 1994-12-29 1999-02-25 Bio Technology General Corp Production of recombinant human insulin by folding a proinsulin hybrid polypeptide obtained from a bacterial cell
DE19735711C2 (de) * 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken

Similar Documents

Publication Publication Date Title
JPH11130798A5 (https=)
RU2302882C2 (ru) Способ получения инсулина или производных инсулина с правильно соединенными цистиновыми мостиками
RU2002126598A (ru) Способ получения инсулина или производных инсулина с правильно соединенными цистиновыми мостиками
EP0397420B1 (en) Enzymatic removal of a protein amino-terminal sequence
Harboe et al. The Activation of Bovine Pepsinogen: SEQUENCE OF THE PEPTIDES RELEASED, IDENTIFICATION OF A PEPSIN INHIBITOR
FI82838B (fi) Foerfarande foer framstaellning av ett terapeutiskt anvaendbart insulinderivat.
HUT69963A (en) Non-naturally-occuring fusion proteins and process for preparing them
JPS6229997A (ja) Ｃ末端にプロリンアミドを有するペプチドの製法
JPS61210099A (ja) 新規な成長ホルモン放出性ペプチド
CN116178480B (zh) 一种硒代半胱氨酸介导的环肽合成方法及其应用
EP0490249B1 (en) Process for the enzymatic preparation of GRF(1-44)NH2
JP5743370B2 (ja) 改善されたフォールディングの空気ガス処理によってインスリンを抽出する方法
JPS6112920B2 (https=)
JPH0952900A (ja) 亜鉛エンドペプチダーゼ２４−１５阻害剤として使用可能な新規ペプチド誘導体
JP2967956B2 (ja) ペプチドまたはその塩
JP3187201B2 (ja) Ｃ末端にプロリンアミドを有するペプチドの製法
WO2003097668A3 (en) Novel process for production of the somatostatin analog, octreotide
JP3249915B2 (ja) Ｌｈ−ｒｈ誘導体の製造方法
Elmore Peptide synthesis
WO1989006241A1 (fr) Sorbine et peptides derives, elevant l'absorption par les muqueuses
JPH05336987A (ja) 酵素的ペプチド合成
JPS61158996A (ja) ペプチド
MXPA98006666A (en) Improved procedure for the obtaining of insulin precursors with cistina bridges correctly uni
JPH05506250A (ja) エンドテリン形成の阻害
HK1003839B (en) Process for preparing peptides having a c-terminal proline amide